Drug Shortage Report for OLIMEL 4.4% E

Last updated on 2017-08-16 History
Report ID 15024
Drug Identification Number 02352516
Brand name OLIMEL 4.4% E
Common or Proper name OLIMEL 4.4% E
Company Name BAXTER CORPORATION
Market Status DORMANT
Active Ingredient(s) HISTIDINE TRYPTOPHAN SODIUM ACETATE TRIHYDRATE ALANINE SOYBEAN OIL DEXTROSE SODIUM GLYCEROPHOSPHATE MAGNESIUM CHLORIDE CALCIUM CHLORIDE POTASSIUM CHLORIDE OLIVE OIL METHIONINE GLYCINE GLUTAMIC ACID L-TYROSINE L-PROLINE L-ARGININE L-VALINE L-ASPARTIC ACID L-THREONINE L-PHENYLALANINE L-LEUCINE L-ISOLEUCINE LYSINE SERINE
Strength(s) 2.64G 0.74G 1.50G 6.41G 8G 154G 3.67G 0.81G 0.52G 2.24G 32G 2.21G 3.07G 2.21G 0.11G 2.64G 4.34G 2.83G 1.28G 2.21G 3.07G 3.07G 2.21G 3.48G 1.75G
Dosage form(s) EMULSION
Route of administration INTRAVENOUS
Packaging size 1000mL
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-07-07
Actual start date 2017-07-07
Estimated end date 2017-08-15
Actual end date 2017-08-15
Shortage status Resolved
Updated date 2017-08-16
Company comments Customers can use the following alternate code upon their clinical judgement • Olimel 5.7% E- CJDB3WP1E • Olimel 5.7% E- CJDB3WP1F • Olimel 5.7% E- CJDB3WP1G
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-07-10 English Compare
v2 2017-07-10 French Compare
v3 2017-07-10 English Compare
v4 2017-07-10 French Compare
v5 2017-07-31 English Compare
v6 2017-07-31 French Compare
v7 2017-08-15 English Compare
v8 2017-08-15 French Compare
v9 2017-08-15 English Compare
v10 2017-08-15 French Compare
v11 2017-08-16 English Compare

Showing 1 to 11 of 11